Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2606 (LINC02606) is a human long non-coding RNA gene annotated by NCBI Gene (GeneID: 100506022) and Ensembl (ENSG00000284693)[1]. LINC02606 belongs to the lincRNA class, which are autonomously transcribed RNA molecules longer than 200 nucleotides, located in intergenic regions of the genome, and do not encode proteins[5]. No specific molecular functions, disease involvement, or drug interactions have been described for LINC02606. LincRNAs generally can act in fine-tuning gene expression, chromatin remodeling, and transcription regulation, but individual functions and relevance depend on specific molecule characterization[5][7]. At present, LINC02606 should be considered a genomic locus of unknown functional significance with no established therapeutic, biomarker, or mechanistic profile.
None: No drug mechanisms are reported for LINC02606
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2606 (LINC02606).